Chaperone Therapeutics Partners With ALS Therapy Development Institute for ALS Research

The ALS Therapy Development Institute has just signed a research partnership with Chaperone Therapeutics, Inc., a company that specializes in treatments that address protein misfolding and neuronal cell loss, the underlying causes of neurodegenerative disease. The new partners will be working on potential treatments for amyotrophic lateral sclerosis (ALS), in order to facilitate preclinical development…

Researchers at the University of Massachusetts Medical School in the United States and the Babraham Institute in the United Kingdom recently revealed a new fly model to study motor neuron degeneration. The study was published in the journal Current Biology and is entitled “…

One of the country’s most accomplished professors of neurosurgery, neural and behavioral sciences and pediatrics at Penn State College of Medicine, James Connor, has just received a three-year grant worth $240,000 from the ALS Society to support his work on a nutrition-based solution that can be given via pain-medication delivery…

In a recent study published in Neurology, Neurosurgery & Psychiatry, a team of researchers found that men working as funeral directors may be at an increased risk for amyotrophic lateral sclerosis. According to the authors this might be related to the high probability of exposure to…

This month, the disease awareness campaign that took the internet and Hollywood by storm is making a comeback. Thanks to the renewed joint efforts of co-founders Pete Frates, Pat Quinn and Anthony Senerchia, a number of celebrities, the Boston Red Sox and Major League Basketball (MLB), the viral ALS Ice…

It has already been a year since the ALS Ice Bucket Challenge took the internet by storm, causing countless American households, celebrities and public figures to show support for ongoing efforts to find a cure for amyotrophic lateral sclerosis. In the wake of the viral campaign, a team of scientists…

Years of work by a team of researchers at Stanford University’s Engineering Department have finally succeeded in yielding a technique that continuously corrects brain readings in order to provide people with spinal cord injuries a more precise technique for tapping out computer commands by using a thought-controlled cursor. A…

Biopharmaceutical company, Neuralstem, Inc. has just announced the US District Court in Maryland has decided to dismiss StemCell, Inc.’s previously filed patent infringement case with prejudice in StemCells, Inc. v. Neuralstem, Inc. in favor of Neuralstem, on July 22, 2015. Neuralstem is most known for its proprietary stem cell technology. It has…

MediciNova, Inc., a biopharmaceutical company established in San Diego, recently announced in a press release that an abstract centered on the ongoing clinical trial evaluating the company’s product MN-166 (ibudilast) for amyotrophic lateral sclerosis (ALS) has been accepted for a presentation at the 26th International Symposium on…

The ALS Association has announced $1.4 million in new funding awarded to advance the search and discovery of biomarkers correlating with key clinical and pathological aspects associated with ALS disease progression. The new funding will be paired with a $539,000 match donation intended for support of ongoing ALS research. There…